Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced Hyponatremia

RecruitingOBSERVATIONAL
Enrollment

232

Participants

Timeline

Start Date

September 26, 2022

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Thiazide-induced Hyponatremia (TIH)
Interventions
OTHER

Data and biosample collection

Collection of spot urine, blood sampling, vital parameters, body weight, medical history, patient questionnaires, drinking protocol, drug diary at at Visit 1 (before thiazide initiation), at Optional 2 hours-challenge, at Visit 2 (4 weeks after thiazide initiation), at Visit 2.1 (4 weeks after dose change), at Visit 3 (3-months after thiazide initiation)

Trial Locations (3)

4031

RECRUITING

University Hospital Basel, Endocrinology, Diabetes and Metabolism, Basel

4410

RECRUITING

Kantonsspital Baselland, Liestal

28935

RECRUITING

Hospital Universitario de Móstoles, Móstoles

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER